Namita Thapar, Whole Time Director, Emcure Pharmaceuticals along with Satish Mehta, MD & CEO, Emcure Pharmaceuticals gives insights on Emcure's IPO Issue opening on July 3 and explains why their profits went down in FY24.
#emcurepharma #pharma #ndtvprofit
For more videos subscribe to our channel: / @ndtvprofitindia
Visit NDTV Profit for more news: www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: www.ndtvprofit.com/research-r...
Follow NDTV Profit here
Twitter: / ndtvprofitindia , / ndtvprofit
LinkedIn: / ndtvprofit
Instagram: / ndtvprofit
Facebook: / ndtvprofit